{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
diazoxide
to a specific field?
There is one exact (name or code) match for diazoxide
Status:
US Approved Rx
(2020)
Source:
ANDA210799
(2020)
Source URL:
First approved in 1973
Source:
HYPERSTAT by SCHERING
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Diazoxide is a drug which was approved by FDA for the treatment of secondary hyperinsulinemia. The drug exerts its action by binding to SUR1 subunit of ATP-sensitive potassium channel that leads to the channel opening.
Showing 1 - 5 of 5 results
Status:
US Approved Rx
(2020)
Source:
ANDA210799
(2020)
Source URL:
First approved in 1973
Source:
HYPERSTAT by SCHERING
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Diazoxide is a drug which was approved by FDA for the treatment of secondary hyperinsulinemia. The drug exerts its action by binding to SUR1 subunit of ATP-sensitive potassium channel that leads to the channel opening.
Status:
Possibly Marketed Outside US
Source:
Octaplasma by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:
First approved in 2013
Source:
BLA125416
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Antibacterial Hand Sanitizer by Shanghai Rayshine ENVI-TECH Developing CO., Ltd.
(2020)
Source URL:
First approved in 2020
Source:
Antibacterial Hand Sanitizer by Shanghai Rayshine ENVI-TECH Developing CO., Ltd.
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2020)
Source:
ANDA210799
(2020)
Source URL:
First approved in 1973
Source:
HYPERSTAT by SCHERING
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Diazoxide is a drug which was approved by FDA for the treatment of secondary hyperinsulinemia. The drug exerts its action by binding to SUR1 subunit of ATP-sensitive potassium channel that leads to the channel opening.
